Global Human Injection Flu Vaccine Market Growth 2022-2028

Home/Global Human Injection Flu Vaccine Market Growth 2022-2028

Global Human Injection Flu Vaccine Market Growth 2022-2028

Pharma & Healthcare, Drug Delivery, Treatments, Pharmaceutical Manufacturing

Publication ID:

ARS0821065

Publication Date:

August 23, 2021

Pages:

Publisher:

Arsta

Region:

Global

$3,660.00

Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.

Printer version

Send by email

PDF version

Tabs

Description

As the global economy recovers in 2021 and the supply of the industrial chain improves, the Human Injection Flu Vaccine market will undergo major changes. According to the latest research, the market size of the Human Injection Flu Vaccine industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.

The global Human Injection Flu Vaccine industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Human Injection Flu Vaccine market during the next few years. The global Human Injection Flu Vaccine market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Injection Flu Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

6 Months to 3 Years
> 3 Years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics

Table of Contents

Table of Content

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Injection Flu Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Injection Flu Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Injection Flu Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Human Injection Flu Vaccine Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Human Injection Flu Vaccine Sales by Type
2.3.1 Global Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Human Injection Flu Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Injection Flu Vaccine Sale Price by Type (2017-2022)
2.4 Human Injection Flu Vaccine Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 > 3 Years
2.5 Human Injection Flu Vaccine Sales by Application
2.5.1 Global Human Injection Flu Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Human Injection Flu Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Injection Flu Vaccine Sale Price by Application (2017-2022)

3 Global Human Injection Flu Vaccine by Company
3.1 Global Human Injection Flu Vaccine Breakdown Data by Company
3.1.1 Global Human Injection Flu Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Human Injection Flu Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Human Injection Flu Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Human Injection Flu Vaccine Revenue by Company (2020-2022)
3.2.2 Global Human Injection Flu Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Human Injection Flu Vaccine Sale Price by Company
3.4 Key Manufacturers Human Injection Flu Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Injection Flu Vaccine Product Location Distribution
3.4.2 Players Human Injection Flu Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Injection Flu Vaccine by Geographic Region
4.1 World Historic Human Injection Flu Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Injection Flu Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Injection Flu Vaccine Annual Revenue by Geographic Region
4.2 World Historic Human Injection Flu Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Human Injection Flu Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Injection Flu Vaccine Annual Revenue by Country/Region
4.3 Americas Human Injection Flu Vaccine Sales Growth
4.4 APAC Human Injection Flu Vaccine Sales Growth
4.5 Europe Human Injection Flu Vaccine Sales Growth
4.6 Middle East & Africa Human Injection Flu Vaccine Sales Growth

5 Americas
5.1 Americas Human Injection Flu Vaccine Sales by Country
5.1.1 Americas Human Injection Flu Vaccine Sales by Country (2017-2022)
5.1.2 Americas Human Injection Flu Vaccine Revenue by Country (2017-2022)
5.2 Americas Human Injection Flu Vaccine Sales by Type
5.3 Americas Human Injection Flu Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Human Injection Flu Vaccine Sales by Region
6.1.1 APAC Human Injection Flu Vaccine Sales by Region (2017-2022)
6.1.2 APAC Human Injection Flu Vaccine Revenue by Region (2017-2022)
6.2 APAC Human Injection Flu Vaccine Sales by Type
6.3 APAC Human Injection Flu Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 Europe
7.1 Europe Human Injection Flu Vaccine by Country
7.1.1 Europe Human Injection Flu Vaccine Sales by Country (2017-2022)
7.1.2 Europe Human Injection Flu Vaccine Revenue by Country (2017-2022)
7.2 Europe Human Injection Flu Vaccine Sales by Type
7.3 Europe Human Injection Flu Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Human Injection Flu Vaccine by Country
8.1.1 Middle East & Africa Human Injection Flu Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Injection Flu Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Injection Flu Vaccine Sales by Type
8.3 Middle East & Africa Human Injection Flu Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine
10.3 Manufacturing Process Analysis of Human Injection Flu Vaccine
10.4 Industry Chain Structure of Human Injection Flu Vaccine

11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Injection Flu Vaccine Distributors
11.3 Human Injection Flu Vaccine Customer

12 World Forecast Review for Human Injection Flu Vaccine by Geographic Region
12.1 Global Human Injection Flu Vaccine Market Size Forecast by Region
12.1.1 Global Human Injection Flu Vaccine Forecast by Region (2023-2028)
12.1.2 Global Human Injection Flu Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Injection Flu Vaccine Forecast by Type
12.7 Global Human Injection Flu Vaccine Forecast by Application

13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Human Injection Flu Vaccine Product Offered
13.1.3 Sanofi Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Human Injection Flu Vaccine Product Offered
13.2.3 CSL Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Human Injection Flu Vaccine Product Offered
13.3.3 GSK Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Human Injection Flu Vaccine Product Offered
13.4.3 Viatris Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Human Injection Flu Vaccine Product Offered
13.5.3 AstraZeneca Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Human Injection Flu Vaccine Product Offered
13.6.3 Hualan Bio Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Human Injection Flu Vaccine Product Offered
13.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Human Injection Flu Vaccine Product Offered
13.8.3 Sinovac Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 Jiangsu GDK
13.9.1 Jiangsu GDK Company Information
13.9.2 Jiangsu GDK Human Injection Flu Vaccine Product Offered
13.9.3 Jiangsu GDK Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jiangsu GDK Main Business Overview
13.9.5 Jiangsu GDK Latest Developments
13.10 KM Biologics
13.10.1 KM Biologics Company Information
13.10.2 KM Biologics Human Injection Flu Vaccine Product Offered
13.10.3 KM Biologics Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 KM Biologics Main Business Overview
13.10.5 KM Biologics Latest Developments

14 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Human Injection Flu Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Injection Flu Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)
Table 6. Global Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Human Injection Flu Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Human Injection Flu Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Human Injection Flu Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)
Table 11. Global Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Human Injection Flu Vaccine Revenue by Application (2017-2022)
Table 13. Global Human Injection Flu Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Human Injection Flu Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Human Injection Flu Vaccine Sales by Company (2020-2022) & (Units)
Table 16. Global Human Injection Flu Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Human Injection Flu Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Human Injection Flu Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Human Injection Flu Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Human Injection Flu Vaccine Producing Area Distribution and Sales Area
Table 21. Players Human Injection Flu Vaccine Products Offered
Table 22. Human Injection Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Injection Flu Vaccine Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Human Injection Flu Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Human Injection Flu Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Human Injection Flu Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Human Injection Flu Vaccine Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Human Injection Flu Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Human Injection Flu Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Human Injection Flu Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Human Injection Flu Vaccine Sales by Country (2017-2022) & (Units)
Table 34. Americas Human Injection Flu Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Human Injection Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Human Injection Flu Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)
Table 38. Americas Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)
Table 40. Americas Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Human Injection Flu Vaccine Sales by Region (2017-2022) & (Units)
Table 42. APAC Human Injection Flu Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Human Injection Flu Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Human Injection Flu Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)
Table 46. APAC Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)
Table 48. APAC Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Human Injection Flu Vaccine Sales by Country (2017-2022) & (Units)
Table 50. Europe Human Injection Flu Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Human Injection Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Human Injection Flu Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)
Table 54. Europe Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)
Table 56. Europe Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Human Injection Flu Vaccine Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Human Injection Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Human Injection Flu Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Human Injection Flu Vaccine
Table 66. Key Market Challenges & Risks of Human Injection Flu Vaccine
Table 67. Key Industry Trends of Human Injection Flu Vaccine
Table 68. Human Injection Flu Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Human Injection Flu Vaccine Distributors List
Table 71. Human Injection Flu Vaccine Customer List
Table 72. Global Human Injection Flu Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Human Injection Flu Vaccine Sales Market Forecast by Region
Table 74. Global Human Injection Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Human Injection Flu Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Human Injection Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Human Injection Flu Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Human Injection Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Human Injection Flu Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Human Injection Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Human Injection Flu Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Human Injection Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Human Injection Flu Vaccine Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Human Injection Flu Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Human Injection Flu Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Human Injection Flu Vaccine Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Human Injection Flu Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Human Injection Flu Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Human Injection Flu Vaccine Product Offered
Table 94. Sanofi Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. CSL Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. CSL Human Injection Flu Vaccine Product Offered
Table 99. CSL Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. CSL Main Business
Table 101. CSL Latest Developments
Table 102. GSK Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. GSK Human Injection Flu Vaccine Product Offered
Table 104. GSK Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. GSK Main Business
Table 106. GSK Latest Developments
Table 107. Viatris Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Viatris Human Injection Flu Vaccine Product Offered
Table 109. Viatris Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Viatris Main Business
Table 111. Viatris Latest Developments
Table 112. AstraZeneca Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. AstraZeneca Human Injection Flu Vaccine Product Offered
Table 114. AstraZeneca Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. AstraZeneca Main Business
Table 116. AstraZeneca Latest Developments
Table 117. Hualan Bio Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Hualan Bio Human Injection Flu Vaccine Product Offered
Table 119. Hualan Bio Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Hualan Bio Main Business
Table 121. Hualan Bio Latest Developments
Table 122. Changchun Institute of Biological Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Changchun Institute of Biological Human Injection Flu Vaccine Product Offered
Table 124. Changchun Institute of Biological Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Changchun Institute of Biological Main Business
Table 126. Changchun Institute of Biological Latest Developments
Table 127. Sinovac Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Sinovac Human Injection Flu Vaccine Product Offered
Table 129. Sinovac Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Sinovac Main Business
Table 131. Sinovac Latest Developments
Table 132. Jiangsu GDK Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiangsu GDK Human Injection Flu Vaccine Product Offered
Table 134. Jiangsu GDK Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Jiangsu GDK Main Business
Table 136. Jiangsu GDK Latest Developments
Table 137. KM Biologics Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. KM Biologics Human Injection Flu Vaccine Product Offered
Table 139. KM Biologics Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. KM Biologics Main Business
Table 141. KM Biologics Latest Developments
List of Figures
Figure 1. Picture of Human Injection Flu Vaccine
Figure 2. Human Injection Flu Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Injection Flu Vaccine Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Human Injection Flu Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Injection Flu Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Trivalent Influenza Vaccine
Figure 10. Product Picture of Quadrivalent Influenza Vaccine
Figure 11. Global Human Injection Flu Vaccine Sales Market Share by Type in 2021
Figure 12. Global Human Injection Flu Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Human Injection Flu Vaccine Consumed in 6 Months to 3 Years
Figure 14. Global Human Injection Flu Vaccine Market: 6 Months to 3 Years (2017-2022) & (Units)
Figure 15. Human Injection Flu Vaccine Consumed in > 3 Years
Figure 16. Global Human Injection Flu Vaccine Market: > 3 Years (2017-2022) & (Units)
Figure 17. Global Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Human Injection Flu Vaccine Revenue Market Share by Application in 2021
Figure 19. Human Injection Flu Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Human Injection Flu Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Human Injection Flu Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Human Injection Flu Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Human Injection Flu Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Human Injection Flu Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Human Injection Flu Vaccine Sales 2017-2022 (Units)
Figure 26. Americas Human Injection Flu Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Human Injection Flu Vaccine Sales 2017-2022 (Units)
Figure 28. APAC Human Injection Flu Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Human Injection Flu Vaccine Sales 2017-2022 (Units)
Figure 30. Europe Human Injection Flu Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Human Injection Flu Vaccine Sales 2017-2022 (Units)
Figure 32. Middle East & Africa Human Injection Flu Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Human Injection Flu Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Human Injection Flu Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Human Injection Flu Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Human Injection Flu Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Human Injection Flu Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Human Injection Flu Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Human Injection Flu Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Human Injection Flu Vaccine
Figure 63. Industry Chain Structure of Human Injection Flu Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles

Companies Covered

Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Report Enquiry

Do you need more information about this report before making a purchase decision or wish to customize this report to suite your requirements?

If yes, then please use the form given below and we will get in touch with you immediately.

Kindly use your official email address and contact number to ensure speedy response.

Name *

Email *

Company

Contact Number *

Report Title *

Your Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Drag or click the correct shape to the grey "drop area".